UNLABELLED: This study describes an [(11)C]acetate rest-stress method to obtain an indirect estimate of myocardial blood flow (MBF) and myocardial oxygen consumption (MVO(2)) in rats. Doxorubicin cardiotoxicity was used to test the usefulness of this approach for the assessment of congestive heart failure. METHODS: [(11)C]Acetate rest-stress studies have been used in clinical research to assess the capacity of the coronary arteries to respond to stress. In this article, we used this approach to assess the cardiotoxicity of doxorubicin in a rat model. The method was first validated in a group of healthy rats and then used to follow the effect of doxorubicin chemotherapy on cardiac function. The effect of doxorubicin on myocardial perfusion and oxygen consumption reserve was measured at rest and under dobutamine stimulation. RESULTS: Validation of the protocol showed a good correlation between the MBF and MVO(2) (r(2)=.68). The doxorubicin-treated group showed a significant (P=.04) decrease in cardiovascular perfusion reserve at 1.3±0.2 compared with the control animals at 1.6±0.2. Similar results were obtained for the MVO(2) reserve (treated 1.8±0.4 vs. controls 2.3±0.3; P=.02). CONCLUSIONS: We describe an [(11)C]acetate PET rest-stress protocol for the assessment of congestive heart failure in rats and its application to the follow-up of cardiotoxicity under doxorubicin chemotherapy. This is a rapid and reliable approach to the measurement of cardiac perfusion and oxygen consumption reserve that could be applied to the development of new strategies to reduce the cardiotoxicity of anthracycline.
UNLABELLED: This study describes an [(11)C]acetate rest-stress method to obtain an indirect estimate of myocardial blood flow (MBF) and myocardial oxygen consumption (MVO(2)) in rats. Doxorubicincardiotoxicity was used to test the usefulness of this approach for the assessment of congestive heart failure. METHODS:[(11)C]Acetate rest-stress studies have been used in clinical research to assess the capacity of the coronary arteries to respond to stress. In this article, we used this approach to assess the cardiotoxicity of doxorubicin in a rat model. The method was first validated in a group of healthy rats and then used to follow the effect of doxorubicin chemotherapy on cardiac function. The effect of doxorubicin on myocardial perfusion and oxygen consumption reserve was measured at rest and under dobutamine stimulation. RESULTS: Validation of the protocol showed a good correlation between the MBF and MVO(2) (r(2)=.68). The doxorubicin-treated group showed a significant (P=.04) decrease in cardiovascular perfusion reserve at 1.3±0.2 compared with the control animals at 1.6±0.2. Similar results were obtained for the MVO(2) reserve (treated 1.8±0.4 vs. controls 2.3±0.3; P=.02). CONCLUSIONS: We describe an [(11)C]acetate PET rest-stress protocol for the assessment of congestive heart failure in rats and its application to the follow-up of cardiotoxicity under doxorubicin chemotherapy. This is a rapid and reliable approach to the measurement of cardiac perfusion and oxygen consumption reserve that could be applied to the development of new strategies to reduce the cardiotoxicity of anthracycline.
Authors: Etienne Croteau; François Bénard; M'hamed Bentourkia; Jacques Rousseau; Michel Paquette; Roger Lecomte Journal: J Nucl Med Date: 2004-11 Impact factor: 10.057
Authors: Shawn A Gregory; Calum A MacRae; Kusai Aziz; Katherine B Sims; Jeremy D Schmahmann; Arash Kardan; Alexander M Morss; Patrick T Ellinor; Ahmed Tawakol; Alan J Fischman; Henry Gewirtz Journal: Coron Artery Dis Date: 2007-02 Impact factor: 1.439
Authors: Paulo J Oliveira; James A Bjork; Maria S Santos; Richard L Leino; M Kent Froberg; António J Moreno; Kendall B Wallace Journal: Toxicol Appl Pharmacol Date: 2004-10-15 Impact factor: 4.219
Authors: Felix T Range; Matthias Paul; Klaus P Schäfers; Tayfun Acil; Peter Kies; Sven Hermann; Otmar Schober; Günter Breithardt; Thomas Wichter; Michael A Schäfers Journal: J Nucl Med Date: 2009-02-17 Impact factor: 10.057
Authors: Pilar Herrero; Joonyoung Kim; Terry L Sharp; John A Engelbach; Jason S Lewis; Robert J Gropler; Michael J Welch Journal: J Nucl Med Date: 2006-03 Impact factor: 10.057
Authors: Laurent Juillard; Sandrine Lemoine; Marc F Janier; Paul Y Barthez; Frédéric Bonnefoi; Maurice Laville Journal: Hypertension Date: 2007-05-14 Impact factor: 10.190
Authors: Ulrich Koellisch; Christoffer Laustsen; Thomas S Nørlinger; Jakob Appel Østergaard; Allan Flyvbjerg; Concetta V Gringeri; Marion I Menzel; Rolf F Schulte; Axel Haase; Hans Stødkilde-Jørgensen Journal: Physiol Rep Date: 2015-08
Authors: Anu Autio; Sauli Uotila; Max Kiugel; Ville Kytö; Heidi Liljenbäck; Nobuyuki Kudomi; Vesa Oikonen; Olli Metsälä; Semi Helin; Juhani Knuuti; Antti Saraste; Anne Roivainen Journal: J Nucl Cardiol Date: 2019-05-29 Impact factor: 5.952
Authors: Elise Roussel; Marie-Claude Drolet; Elisabeth Walsh-Wilkinson; Wahiba Dhahri; Dominic Lachance; Suzanne Gascon; Otman Sarrhini; Jacques A Rousseau; Roger Lecomte; Jacques Couet; Marie Arsenault Journal: Biomed Res Int Date: 2015-10-25 Impact factor: 3.411
Authors: Emmeli F R Mikkelsen; Christian Østergaard Mariager; Thomas Nørlinger; Haiyun Qi; Rolf F Schulte; Steen Jakobsen; Jørgen Frøkiær; Michael Pedersen; Hans Stødkilde-Jørgensen; Christoffer Laustsen Journal: Sci Rep Date: 2017-11-22 Impact factor: 4.379